Should I go for the HT or try fin and min first? 9/19/2026
Similar Community Posts Join
5 / 5 resultscommunity 7 months fin, 10 months min, 4 months dut. Should I continue?
The user has been using finasteride for 7 months, minoxidil for 10 months, and dutasteride for 4 months with minimal results and is considering stopping treatment. Replies suggest continuing treatment, adding microneedling, and checking DHT levels.
community Gents, heres a 2-year comparison of Fin only treatment. Starting Oral Min this month. Is their some progression? Should I make a switch to Dut?
The user has been using finasteride for two years to stabilize hair loss and is considering adding oral minoxidil for volume. They are also contemplating switching to dutasteride and possibly getting a hair transplant for better results.
community M20 on Fin+Min for 1 Year – Crown Still Thin, Should I Add Dut/Oral Min?
A 20-year-old has been using finasteride and topical minoxidil for a year but is considering adding oral minoxidil, dutasteride, and biotin due to unsatisfactory results. Opinions vary, with some suggesting patience and others recommending different treatments, but caution is advised against using multiple oral drugs due to potential side effects.
community 2 full years Fin and Min — I think it’s progress 48 year old
A 48-year-old reported significant hair regrowth after two years using finasteride and minoxidil, with better results on the temples and using a dermastamp for the crown. The user experienced no side effects from the treatments.
community HT scheduled. Am I over reacting?
The user has scheduled a hair transplant after stabilizing hair loss with finasteride and minoxidil, considering additional dermarolling. They are advised to use 2500-3000 grafts conservatively for temple filling without lowering the hairline too much.
Related Research
6 / 6 results
research Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?
This paper discusses mechanisms by which various chemicals disrupt male sexual differentiation, concluding that mixture risk assessments should include a broader set of compounds beyond phthalates to address cumulative reproductive health risks.
research Safety of dermatologic medications in pregnancy and lactation
Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.
research The Dynamics of the Skin’s Immune System
This review discusses the protective roles of skin-resident immune cells in maintaining tissue homeostasis and facilitating wound healing, but reports no new experimental findings.
research Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis
This study identified a coexpression network and key genes associated with thyroid eye disease, potentially aiding in its treatment and diagnosis.
research The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
This review reported that despite identifying over 200 symptoms associated with long COVID, significant gaps and controversies remain in understanding its diagnosis, pathophysiology, risk factors, and the impact of viral strains and vaccination.
research The Who’s, What’s, and “Y”s: Y Sex Chromosome Loss and Methylation for Analysis in Male Aging and Mortality and Forensic Science Applications
This review highlights the potential for using the Y chromosome in epigenetic analyses to better understand male-specific aging and disease mechanisms.